Skip to main content
EIKO LIFESCIENCES LIMITED logo

EIKO LIFESCIENCES LIMITED — Investor Relations & Filings

Ticker · 540204 ISIN · INE666Q01016 LEI · 335800TM287FGN1STE49 BSE.NS Manufacturing
Filings indexed 2 across all filing types
Latest filing 2026-05-25 Regulatory Filings
Country IN India
Listing BSE.NS 540204

About EIKO LIFESCIENCES LIMITED

https://www.eikolifesciences.com

Eiko Lifesciences Limited specializes in the research, development, and manufacturing of specialty chemicals and pharmaceutical intermediates. The company provides a broad portfolio of chemical products tailored for applications in the pharmaceutical, agrochemical, and personal care sectors. Its core operations involve the synthesis of complex chemical compounds and niche intermediates, supported by a focus on process innovation and quality assurance. By utilizing advanced technical expertise, the organization delivers customized solutions that cater to the specific requirements of global manufacturers, facilitating the production of active pharmaceutical ingredients and specialized industrial formulations.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for the year ended on 31st March 2026.
Regulatory Filings Classification · 92% confidence The document is titled “Annual Secretarial Compliance Report” and includes certifications by a Company Secretary under SEBI LODR Regulation 24A and SEBI (Prohibition of Insider Trading) Regulations. It does not contain financial statements or detailed report data, but is an officer attestation/compliance certificate submitted to the stock exchange. Under the Certification Rule, such compliance certifications are classified as a general regulatory filing, not as an annual report or interim report.
2026-05-25 English
Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve The Audited Standalone and ....
Regulatory Filings Classification · 87% confidence The document is a regulatory notice under SEBI Listing Regulations (Regulation 29) informing the stock exchange of a scheduled board meeting to consider and approve audited financial results. It does not include actual financial results, report attachments, nor is it a management change announcement. This falls under general regulatory announcements—best classified as Regulatory Filings (RNS).
2026-05-21 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.